HIGHLIGHTS
- who: Robert Stuver and Alison J. Moskowitz from the New York, NY, USA have published the article: Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell Lymphoma, in the Journal: Cancers 2023, 15, 589. of /2023/
- what: The clinical management of R/R T-cell lymphomas is challenging owing to the rarity and heterogeneity of these diseases, historically forcing clinicians to rely on salvage therapy borrowed from other aggressive lymphoma subtypes.
SUMMARY
The peripheral T-cell lymphomas (PTCL) encompass a broad class of heterogeneous clinicopathologic entities unified in their derivation from . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.